{
    "title": "U.S. FDA approves Mirati's lung cancer drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11530899/U-S-FDA-approves-Miratis-lung-cancer-drug.html",
    "date": "2022-12-12",
    "keywords": [
        "drug",
        "lung",
        "cancer",
        "therapy",
        "trial",
        "combination",
        "beasley",
        "miratis",
        "form",
        "keytruda",
        "dec",
        "food",
        "administration",
        "company",
        "monday",
        "trading",
        "adult",
        "test",
        "gene",
        "nonsmall",
        "cell",
        "disease",
        "brand",
        "name",
        "krazati",
        "price",
        "milligram",
        "tablet180",
        "count",
        "bottle",
        "inhibitor",
        "amgen",
        "incs",
        "lumakras",
        "secondline",
        "year",
        "mirati",
        "executive",
        "david",
        "meek",
        "interview",
        "choice",
        "option",
        "month",
        "presentation",
        "adagrasib",
        "amp",
        "cos",
        "immunotherapy",
        "treatment",
        "half",
        "protein",
        "bar",
        "superiority",
        "standard",
        "care",
        "wall",
        "street",
        "efficacy",
        "safety",
        "strategy",
        "path",
        "possibility",
        "acquisition",
        "table",
        "capital",
        "analyst",
        "seigerman",
        "research",
        "note",
        "approval",
        "reporting",
        "deena",
        "mahobe",
        "bengaluru",
        "editing",
        "bill",
        "berkrot",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}